What Forus does
Forus, which rebranded from Tandem in May 2026, runs an AI-powered network that connects doctors, pharmacies, payers and biopharma companies. Its AI agents work each prescription through prior authorization, benefit verification, appeals, pharmacy routing and enrollment in affordability programs, and the platform integrates with major EHRs. It is free for doctors and patients, and biopharma companies pay for services. Forus says it works with 9 of the top 15 global biopharma companies.
Forus is a healthcare tool on Falcoscan. AI network that automates prior authorizations and medication access for prescribers. Falcoscan rates Forus with an Opportunity score of 86/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: hot. Forus is founded in 2023, currently at Series_c stage. Pricing: Free.